AstraZeneca Pharma India Receives CDSCO Approval for Additional Calquence Indication in Mantle Cell Lymphoma 21/05/2026 / Business Updates / Regulatory Approval / Product Commercial Expansion AstraZeneca Pharma India Receives CDSCO Approval for Additional Calquence Indication in Mantle Cell Lymphoma Read Post »
Biocon Receives Health Canada Approval for Bosaya and Vevzuo Biosimilars 21/04/2026 / Business Updates / Regulatory Approval / Product Commercial Expansion Biocon Receives Health Canada Approval for Bosaya and Vevzuo Biosimilars Read Post »
